CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2012

Jul 3, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2012-07-02

Reporting Person: MCENANY PATRICK J (Director, President and CEO, 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-07-02	Common Stock, par value $0.001 per share	P	30500	$0.5383	Acquired	3249297	Direct
2012-07-03	Common Stock, par value $0.001 per share	P	700	$0.535	Acquired	3249997	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, par value $0.001 per share	145922	Indirect

Footnotes

F1: Shares are owned by the Reporting Person's spouse.